对心房动管理的挑战和机遇
Minsi Cai1, Jordi Heijman1,2
1Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht 6229HX, The Netherlands.
概括
尽管取得了进展,但心房动 (AF) 管理仍面临挑战. 未来的机遇在于先进的监测,计算模型和新的疗法,以改善这种常见心律失常的诊断和治疗.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 内部医学 内部医学
背景情况:
- 在全球范围内,心房动 (AF) 是最常见的持续性心律失常.
- AF与不良的临床结果和大量的医疗保健费用有关.
- 目前的管理重点是抗凝血,速率/节律控制和并发症管理.
研究的目的:
- 审查心房的管理当前的挑战.
- 探索未来的机会和AF诊断和治疗的进步.
- 总结AF领域的关键问题和潜在解决方案.
主要方法:
- 这是一个叙事评论.
- 它综合了有关AF管理的当前知识.
- 它讨论了最近的进展和未来的方向.
主要成果:
- 尽管取得了进展,但在了解AF机制,其自然史和治疗疗效方面仍然存在重大挑战.
- 仍然存在低于最佳的检测方法和治疗选择.
- 监测,计算建模和治疗方面的进步提供了潜在的解决方案.
结论:
- 解决AF的复杂性需要一个多方面的方法.
- 新技术和治疗策略对于AF护理的范式转变至关重要.
- 未来的研究应该专注于个性化和改进的AF管理策略.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
114
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
114
Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Dysrhythmias VII: Nursing Management of Dysrhythmias
112
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
112
Aortic Regurgitation III: Medical Management
53
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
53
Rheumatic Heart Disease III: Medical Management
36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36


